Amphastar Pharmaceuticals

AMPH87

High Quality

$44.64arrow_drop_down1.91%-$0.86

High Quality

AMPH87

$44.64

arrow_drop_down1.91%-$0.86

High Quality

Performance History

Key Stats
Open	$45.71
Prev. Close	$45.46
EPS	3.01
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	44.00	46.82
52 Week Range	36.56	65.92

Ratios







EPS	3.01

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) is a specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of generic and proprietary injectable and inhalation products. The company is headquartered in Rancho Cucamonga, California. Amphastar's product portfolio includes a wide range of medications used in emergency care, such as epinephrine, sodium bicarbonate, and calcium gluconate. Additionally, the company produces inhalation products for the treatment of respiratory conditions, including asthma and chronic obstructive pulmonary disease.

As of the latest market close, Amphastar Pharmaceuticals Inc has a market capitalization of approximately $1.5 billion. The stock has a PEG ratio of 2.32, indicating that the company's earnings growth potential may be slightly overvalued compared to its industry peers. However, it is worth noting that Amphastar Pharmaceuticals Inc has outperformed the average PEG ratio of its industry.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Dr. Yongfeng Zhang Ph.D.
Headquarters: Rancho Cucamonga
Employees: 1615
Exchange: NASDAQ

add Amphastar Pharmaceuticals to watchlist

Keep an eye on Amphastar Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Amphastar Pharmaceuticals 's (AMPH) price per share?

The current price per share for Amphastar Pharmaceuticals (AMPH) is $44.64. The stock has seen a price change of -$0.87 recently, indicating a -1.91% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Amphastar Pharmaceuticals (AMPH)?

For Amphastar Pharmaceuticals (AMPH), the 52-week high is $65.92, which is 47.67% from the current price. The 52-week low is $36.56, the current price is 22.1% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Amphastar Pharmaceuticals (AMPH) a growth stock?

Amphastar Pharmaceuticals (AMPH) has shown an average price growth of -3.36% over the past three years. It has received a score of 84 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Amphastar Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Amphastar Pharmaceuticals (AMPH) stock price performance year to date (YTD)?

As of the latest data, Amphastar Pharmaceuticals (AMPH) has a year-to-date price change of -28.34%. Over the past month, the stock has experienced a price change of -11.23%. Over the last three months, the change has been -7.29%. Over the past six months, the figure is 6.35%. Looking at a longer horizon, the five-year price change stands at 138.21%.

help

Is Amphastar Pharmaceuticals (AMPH) a profitable company?

Amphastar Pharmaceuticals (AMPH) has a net income of $137.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 53.38% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 29.83% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $644.4M, with a revenue growth rate of 29.14%, providing insight into the company's sales performance and growth. The gross profit is $343.97M. Operating income is noted at $196.99M. Furthermore, the EBITDA is $276.85M.

help

What is the market capitalization of Amphastar Pharmaceuticals (AMPH)?

Amphastar Pharmaceuticals (AMPH) has a market capitalization of $2.15B. The average daily trading volume is 45.08, indicating the stock's liquidity and investor engagement.